‹ All Posts
Unite Technologies Financial

10th Mar · SEBI-Registered Analyst

Technical Analysis Ajanta Pharma

The stock

AJANTPHARM
is currently in a strong recovery phase. After hitting a peak near 3400 in late 2024 it underwent a significant correction. However since early 2026 the stock has formed a Rounded Bottom or a U-shaped recovery which is a bullish signal. It is currently trading around the 2999.80 mark. Immediate resistance the first major hurdle is at 3100. If it breaks this the next target is the previous lifetime high near 3300–3400. Immediate resistance the first major hurdle is at 3100. If it breaks this the next target is the previous lifetime high near 3300–3400. Major floor the 2400 zone acts as a long-term demand zone where buyers consistently step in. Volume looking at the bottom of the chart the volume bars have remained relatively steady. For a confirmed breakout above 3000 we would ideally want to see a spike in green volume bars to show institutional buying interest. The stock is making Higher Highs and Higher Lows on the recent leg of the chart which indicates that the short-to-medium-term trend is firmly Bullish. Technical analysis is based on historical patterns and does not guarantee future results. Always use a Stop-Loss to manage your risk.

#WatchOutFor#EquityResearch#TechnicalViews
1,089 likes·84 comments